# FDA Inspection 1111018 - Biomat USA Inc - October 10, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/cbc79eb4-5b9e-4c9b-afab-326addab092f
Source feed: FDA_Inspections

> FDA Inspection 1111018 for Biomat USA Inc on October 10, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1111018
- Company Name: Biomat USA Inc
- Inspection Date: 2019-10-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1031049 - 2017-10-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/af098882-cec6-463e-866e-9d95f01cbb86)
- [FDA Inspection 969079 - 2016-04-25](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8b65094c-0ab8-444d-a746-079fb87e679f)
- [FDA Inspection 807222 - 2012-10-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/99154883-eb33-43c6-a939-64bfc83ca240)
- [FDA Inspection 708599 - 2011-02-04](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/495d8aed-42b0-44c0-adeb-e7e7c5d041db)

Company: https://www.keypedia.com/companies/biomat-usa-inc/d15f5a72-a99d-4998-af29-711fee3da4fe

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d